Titan Biotech Limited (BOM:524717)

Market Cap	10.02B +65.5%
Revenue (ttm)	1.93B +19.4%
Net Income	272.03M +21.0%
EPS	32.92 +21.0%
Shares Out	8.26M
PE Ratio	36.83
Forward PE	n/a
Dividend	2.00 (0.16%)
Ex-Dividend Date	Sep 19, 2025

Volume	39,608
Average Volume	10,090
Open	1,162.00
Previous Close	1,137.90
Day's Range	1,125.00 - 1,269.95
52-Week Range	373.65 - 1,419.00
Beta	0.27
RSI	72.15
Earnings Date	Feb 12, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1992
• Employees: 467
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524717

Financial Performance

In fiscal year 2025, Titan Biotech's revenue was 1.56 billion, a decrease of -4.65% compared to the previous year's 1.64 billion. Earnings were 215.32 million, a decrease of -13.36%.